Publication Name	World Journal of Clinical Cases
Manuscript ID	96945
Country	Italy

Category	Microbiology
Manuscript Type	Letter to the Editor
Article Title	Role of high dose amoxicillin dual therapy for Helicobacter pylori eradication in an Irish cohort: A prospective study
Manuscript Source	Invited Manuscript
All Author List	Raffaele Palmirotta, Concetta Cafiero and Marica Colella
Funding Agency and Grant Number
Corresponding Author	Raffaele Palmirotta, MD, PhD, Associate Professor, Interdisciplinary Department of Medicine, University of Bari “Aldo Moro”, P.zza G. Cesare, Bari 70124, Italy. raffaelepalmirotta@gmail.com
Key Words	Triple therapy; High dose amoxicillin dual therapy; High dose amoxicillin; Helicobacter pylori eradication; Helicobacter pylori
Core Tip	Costigan et al conducted a prospective study, to test high dose amoxicillin dual therapy (HDADT) for Helicobacter pylori infections in an Irish cohort. Ireland, indeed, is a high dual-resistance country for clarithromycin and metronidazole, so the traditional treatment does not work well; in addition, bismuth is not available there, and for this reason, the only recommended is HDADT. The study considered in this editorial is the first to be conducted in Ireland, and it shows that HDADT does not always guarantee bacterial eradication.
Citation	<p>Palmirotta R, Cafiero C, Colella M. Role of high dose amoxicillin dual therapy for Helicobacter pylori eradication in an Irish cohort: A prospective study. <i>World J Clin Cases</i> 2024; 12(35): 6859-6863</p>

Received	2024-05-18 16:27
Peer-Review Started	2024-05-18 16:27
To Make the First Decision
Return for Revision	2024-09-06 02:43
Revised	2024-09-19 14:35
Second Decision	2024-10-09 02:39
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-10-09 08:34
Articles in Press	2024-10-09 08:34
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-10-14 23:59
Typeset the Manuscript	2024-10-17 00:29

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com